Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis

참고문헌 (59)

1. Ahrens, M., "DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery", Cell Metab, 18, pp.296~302 (2013)
2. Danford, C. J., "Non-alcoholic fatty liver disease : a narrative review of genetics", J. Biomed. Res, 32, pp.389~400 (2018)
3. Gerhard, G. S., "Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways", Clin. Epigenetics, 10, pp.93~ (2018)
4. Botello-Manilla, A. E., "Genetics and epigenetics purpose in nonalcoholic fatty liver disease", Expert. Rev. Gastroenterol. Hepatol, 14, pp.733~748 (2020)
5. Hyun, J., "DNA methylation in nonalcoholic fatty liver disease", Int. J. Mol. Sci, 21, pp.8138~ (2020)
6. Robertson, K. D., "DNA methylation and human disease", Nat. Rev. Genet, 6, pp.597~610 (2005)
7. Hamidi, T., "Genetic alterations of DNA methylation machinery in human diseases", Epigenomics, 7, pp.247~265 (2017)
8. Urbano, A., "Gene-specific targeting of DNA methylation in the mammalian genome", Cancers, 11, pp.1515~ (2019)
9. Cencioni, C., "Epigenetic mechanisms of hyperglycemic memory", Int. J. Biochem. Cell Biol, 51, pp.155~158 (2014)
10. Pogribny, I. P., "Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet", J. Hepatol, 51, pp.176~186 (2009)
11. Keleher, M. R., "A high-fat diet alters genome-wide DNA methylation and gene expression in SM", J mice, 2018, pp.19, 888~
12. Cordero, P., "Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet", Genes Nutr, 8, pp.105~113 (2013)
13. Tian, W., "Brahma-related gene 1 bridges epigenetic regulation of proinflammatory cytokine production to steatohepatitis in mice", Hepatology, 58, pp.576~588 (2013)
14. Tryndyak, V. P., "Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet", Mol. Nutr. Food Res, 55, pp.411~418 (2011)
15. Nagase, T., "Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro", DNA Res, 7, pp.347~355 (2000)
16. Kamal, M., "C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity", Mol. Immunol, 46, pp.991~998 (2009)
17. Grimbert, P., "Truncation of C-mip(Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization", J. Exp. Med, 198, pp.797~807 (2003)
18. Cao, Y., "Opposite genetic effects of CMIP polymorphisms on the risk of type 2 diabetes and obesity : a family-based study in China", Int. J. Mol. Sci, 19, pp.1011~ (2018)
19. Kim, H., "The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophages", Sci. Rep, 7, pp.7591~ (2017)
20. Schmittgen, T. D, "Analyzing real-time PCR data by the comparative C T method", Nat. Protoc, 3, pp.1101~ (2008)
21. Sherman, B. T., "Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources", Nat. Protoc, 4, pp.44~57 (2009)
22. Guhathakurta, S., "Targeted attenuation of elevated histone marks at SNCA alleviates alpha-synuclein in Parkinson’s disease", EMBO Mol. Med, 13, pp.e12188~ (2021)
23. Nanan, K. K., "TET-catalyzed 5-carboxylcytosine promotes CTCF binding to suboptimal sequences genome-wide", iScience, 19, pp.326~339 (2019)
24. Holwerda, S. J., "CTCF : the protein, the binding partners, the binding sites and their chromatin loops", Philos. Trans. R. Soc. Lond. B Biol. Sci, 368, pp.20120369~ (2013)
25. Zeng, J., "Effects and therapeutic mechanism of Yinzhihuang on steatohepatitis in rats induced by a high-fat, high-cholesterol diet", J. Dig. Dis, 21, pp.179~188 (2020)
26. Grohmann, M., "Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC", Cell, 175, pp.1289~1306 (2018)
27. Adams, L. A., "The natural history of nonalcoholic fatty liver disease : a population-based cohort study", Gastroenterology, 129, pp.113~121 (2015)
28. Sun, C., "Potential epigenetic mechanism in non-alcoholic fatty liver disease", Int. J. Mol. Sci, 16, pp.5161~5179 (2015)
29. Podrini, C., "Redox homeostasis and epigenetics in non-alcoholic fatty liver disease(NAFLD)", Curr. Pharm. Des, 19, pp.2737~2746 (2013)
30. Chung, M. Y., "Tannic acid, a novel histone acetyltransferase inhibitor, prevents non-alcoholic fatty liver disease both in vivo and in vitro model", Mol. Metab, 19, pp.34~48 (2019)
31. Lee, J. H., "Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition", Nutrients, 6, pp.3303~3325 (2014)
32. Pirola, C. J., "Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease", Gut, 62, pp.1356~1363 (2013)
33. Lyall, M. J., "Non-alcoholic fatty liver disease(NAFLD)is associated with dynamic changes in DNA hydroxymethylation", Epigenetics, 15, pp.61~71 (2020)
34. Sayols-Baixeras, S., "DNA methylation and high-density lipoprotein functionality-brief report : the REGICOR study(Registre Gironi del Cor)", Arterioscler. Thromb. Vasc. Biol, 37, pp.567~569 (2017)
35. Bestor, T. H., "Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain", EMBO J, 11, pp.2611~2617 (1992)
36. Gao, L., "Comprehensive structure-function characterization of DNMT3B and DNMT3A reveals distinctive de novo DNA methylation mechanisms", Nat. Commun, 11, pp.3355~ (2020)
37. Liu, X., "The EZH2-H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo", YAP pathway upstream effector, in breast cancer epithelial cells, 2018, pp.51, 243~256
38. Redl, E., "Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis", Life Sci. Alliance, 4, pp.e202000794~ (2021)
39. Deaton, A. M., "CpG islands and the regulation of transcription", Genes Dev, 25, pp.1010~1022 (2011)
40. Zhu, H., "Transcription factors as readers and effectors of DNA methylation", Nat. Rev. Genet, 17, pp.551~565 (2016)
41. Yoshino, Y., "NA methylation changes in intron 1 of triggering receptor expressed on myeloid cell 2 in Japanese schizophrenia subjects", Front. Neurosci, 11, pp.275~ (2017)
42. Funahashi, Y., "DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies", Psychiatry Clin. Neurosci, 71, pp.28~35 (2017)
43. Yoshino, Y., "Elevated mRNA expression and low methylation of SNCA in Japanese Alzheimer’s disease subjects", J. Alzheimers Dis, 54, pp.1349~1357 (2016)
44. Xue, Q., "Methylation of a novel CpG island of intron 1 is associated with steroidogenic factor 1 expression in endometriotic stromal cells", Reprod. Sci, 21, pp.395~400 (2014)
45. Zhang, X., "Methylation of a single intronic CpG mediates expression silencing of the PMP24 gene in prostate cancer", Prostate, 70, pp.765~776 (2010)
46. Li, H., "Analysis of intron sequence features associated with transcriptional regulation in human genes", PLoS ONE, 7, pp.e46784~ (2012)
47. Wang, H., "Widespread plasticity in CTCF occupancy linked to DNA methylation", Genome Res, 22, pp.1680~1688 (2012)
48. Cheng, C. K., "The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer", Cancer Res, 65, pp.8646~8654 (2005)
49. Marina, R. J., "TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing", EMBO J, 35, pp.335~355 (2016)
50. Rasmussen, K. D., "TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells", Genome Res, 29, pp.564~575 (2019)
51. Kong, L., "A primary role of TET proteins in establishment and maintenance of de novo bivalency at CpG islands", Nucleic Acids Res, 44, pp.8682~8692 (2016)
52. Walczak, R., "PPARadigms and PPARadoxes : expanding roles for PPARgamma in the control of lipid metabolism", J. Lipid Res, 43, pp.177~186 (2002)
53. Fu, M., "Cyclin D1 inhibits peroxisome proliferator-activated receptor gammamediated adipogenesis through histone deacetylase recruitment", J. Biol. Chem, 280, pp.16934~16941 (2005)
54. Wang, C., "Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation", Mol. Cell. Biol, 23, pp.6159~6173 (2003)
55. Hanse, E. A., "Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4alpha", Cell Cycle, 11, pp.2681~2690 (2012)
56. Kim, B. H., "Interferon-induced guanylate-binding proteins in inflammasome activation and host defense", Nat. Immunol, 17, pp.481~489 (2016)
57. Lumeng, C. N., "Obesity induces a phenotypic switch in adipose tissue macrophage polarization", J. Clin. Invest, 117, pp.175~184 (2007)
58. Kintscher, U., "T-lymphocyte infiltration in visceral adipose tissue : a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance", Arterioscler. Thromb. Vasc. Biol, 28, pp.1304~1310 (2008)
59. Lacey, D. C., "Defining GM-CSF-and macrophage-CSF-dependent macrophage responses by in vitro models", J. Immunol, 188, pp.5752~5765 (2012)

관련 논문AI추천